CliffBio
small molecule

TRIFERIC

FERRIC PYROPHOSPHATE CITRATE

Loss of exclusivity—loss of exclusivity
CompanyRockwell Medical →See this company's full patent-cliff portfolio

Drug detail

Brand nameTRIFERIC
Active ingredientFERRIC PYROPHOSPHATE CITRATE
Strength272MG IRON/50ML (5.44MG IRON/ML)
Dosage formSOLUTION
RouteINTRAVENOUS
ModalitySmall molecule
FDA approvalSeptember 2015
Marketing statusDISCN

More from Rockwell Medical

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.

TRIFERIC patent cliff — loss of exclusivity — | CliffBio